1-4 of 4
Ping Tu
Close
Sort by
Journal Articles

PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma

Fengjie Liu, Yumei Gao, Bufang Xu, Shan Xiong, Shengguo Yi, Jingru Sun, Zhuojing Chen, Xiangjun Liu, Yingyi Li, Yuchieh Lin, Yujie Wen, Yao Qin, Shuxia Yang, Hang Li, Trilokraj Tejasvi, Lam Tsoi, Ping Tu, Xianwen Ren, Yang Wang
Journal: Blood
Blood (2022) 139 (4): 554–571.
https://doi.org/10.1182/blood.2021012091
Published: 2022
Includes: Supplemental data
Journal Articles

Phase II Study of Chidamide, a New Subtype-Selective Oral Histone Deacetylase Inhibitor, in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma

Yuankai Shi, MD PhD, Mei Dong, MD, Jun Zhu, MD, Daobin Zhou, MD, Huiqiang Huang, MD, Ping Tu, MD, Weijing Zhang, MD, Xiaonan Hong, MD, Xielan Zhao, MD, Jianfang Sun, MD, Yuehua Liu, MD, Lugui Qiu, MD PhD, ZhiXiang Shen, MD, Jifeng Feng, MD, Xiaoyan Ke, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1513.
https://doi.org/10.1182/blood.V126.23.1513.1513
Published: 2015
Journal Articles

SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30 + lymphoproliferative disease by repressing p21

Yang Wang, Xiaoguang Gu, Gaolei Zhang, Lin Wang, Tingting Wang, Yun Zhao, Xiuyan Zhang, Youwen Zhou, Marshall Kadin, Ping Tu
Journal: Blood
Blood (2014) 123 (22): 3452–3461.
https://doi.org/10.1182/blood-2013-10-534693
Published: 2014
Includes: Supplemental data
Journal Articles

Deficiency of SATB1 expression in Sézary cells causes apoptosis resistance by regulating FasL/CD95L transcription

Yang Wang, Mingwan Su, Liang L. Zhou, Ping Tu, Xuejun Zhang, Xiaoyan Jiang, Youwen Zhou
Journal: Blood
Blood (2011) 117 (14): 3826–3835.
https://doi.org/10.1182/blood-2010-07-294819
Published: 2011
Includes: Supplemental data